Form 4 for WGS GeneDx Holdings Corp.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001689575-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15+ | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +30.7K | 75.6K | +68% | $0 |
| DM | 2026-03-17 | 2026-03-16 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $76.80 | -17.2K | 68.4K | -20% | -$1.32M |
| DM | 2026-03-17 | 2026-03-15+ | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -30.7K | 35.8K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-03-15 | M | A | 11,921 | $0.00 | 56,876 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2026-03-16 | M | A | 18,750 | $0.00 | 75,626 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 3 | Common | Class A Common Stock | 2026-03-16 | S | D | 772 | $77.94 | 58,447 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.75 to $78.16 per share, inclusive. (F6) Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 58,447 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 414,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms. |
| 4 | Common | Class A Common Stock | 2026-03-16 | S | D | 9,229 | $77.05 | 59,219 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.74 to $77.71 per share, inclusive. |
| 5 | Common | Class A Common Stock | 2026-03-16 | S | D | 7,178 | $76.35 | 68,448 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.735 to $76.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4. |
| 6 | Derivative | Restricted Stock Unit | 2026-03-16 | M | D | 18,750 | $0.00 | 75,000 | D | — · — to — | 18,750 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F8) 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date. |
| 7 | Derivative | Restricted Stock Unit | 2026-03-15 | M | D | 11,921 | $0.00 | 35,763 | D | — · — to — | 11,921 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F7) 25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date. |